Mantle Cell Lymphoma (MCL)
Also known as: MCL / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Mantle-Cell Lymphomas / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B-cell Mantle Cell Lymphoma / Mantle Cell Lymphomas / MCLS / Mantle cell lymphoma (morphologic abnormality) / Mantle zone lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphoma (disorder) / Non-Hodgkin lymphoma, unspecified / Non-Hodgkin lymphoma (morphologic abnormality) / Non-Hodgkin's lymphoma / Non-Hodgkin's lymphoma NOS / Malignant lymphoma - small cleaved cell (disorder) / Lymphoma, Non-Hodgkin / Non-Hodgkin's lymphoma (disorder) / Lymphoma (non-Hodgkin's) / Mucocutaneous lymph node syndrome [Kawasaki] / Kawasaki's disease / Acute febrile mucocutaneous lymph node syndrome (MCLS) / Acute febrile mucocutaneous lymph node syndrome (disorder) / Mucocutaneous Lymph Node Syndrome
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11703 | Acalabrutinib | A Bruton tyrosine kinase inhibitor used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma. |
| DB00188 | Bortezomib | A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. |
| DB00291 | Chlorambucil | A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas. |
| DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
| DB15035 | Zanubrutinib | A kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy. |